Search Results - "Smeding, L"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance by Tjong, F V Y, Brouwer, T F, Smeding, L, Kooiman, K M, de Groot, J R, Ligon, D, Sanghera, R, Schalij, M J, Wilde, A A M, Knops, R E

    Published in Europace (London, England) (01-11-2016)
    “…The subcutaneous implantable cardioverter-defibrillator (S-ICD) and leadless pacemaker (LP) are evolving technologies that do not require intracardiac leads…”
    Get full text
    Journal Article
  2. 2

    Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator? by van der Stuijt, W., Pepplinkhuizen, S., de Veld, J.A., Quast, A.B.E., van Halm, V.P., Bijsterveld, N.R., Olde Nordkamp, L.R.A., Wilde, A.A.M., Smeding, L., Knops, R.E.

    Published in International journal of cardiology (01-03-2024)
    “…The first step-down defibrillation studies in the subcutaneous implantable cardioverter-defibrillator (S-ICD) described a defibrillation threshold (DFT) of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sex differences in shocks and device-related complications in subcutaneous implantable-cardioverter defibrillator patients by De Veld, J, Sivanesan, S, Pepplinkhuizen, S, Smeding, L, Knops, R E

    Published in European heart journal (28-10-2024)
    “…Abstract Background The use of implantable cardioverter-defibrillators (ICDs) improves the life expectancy of patients at risk of sudden cardiac death…”
    Get full text
    Journal Article
  5. 5

    Clinical relevance of the single-lead ECG of the Apple Watch by Pepplinkhuizen, S, Hoeksema, W F, Van Der Stuijt, W, Smeding, L, Wilde, A A M, Knops, R E

    Published in European heart journal (03-10-2022)
    “…Abstract Introduction The Apple Watch (AW) is one of the first commercially available wearable with built-in electrocardiogram (ECG) electrodes to perform a…”
    Get full text
    Journal Article
  6. 6

    Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation by Pepplinkhuizen, S, Kors, N, De Veld, J A, Dijkshoorn, L A, Bijsterveld, N R, De Weger, A, Smeding, L, Wilde, A A M, Olde Nordkamp, L R A, Knops, R E

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction The PRAETORIAN trial, which randomized S-ICD versus TV-ICD in patients with a class I or IIa indication for ICD therapy, showed that…”
    Get full text
    Journal Article
  7. 7

    Reasons for replacement and extraction of the subcutaneous implantable cardioverter-defibrillator in a large cohort by Van Der Stuijt, W, Pepplinkhuizen, S, Smeding, L, Olde Nordkamp, LRA, Wilde, AAM, Knops, RE

    Published in Europace (London, England) (19-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is proven to be a…”
    Get full text
    Journal Article
  8. 8

    Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial by Pepplinkhuizen, S, Olde Nordkamp, L R A, Kuschyk, J, Bonnemeier, H, El-Chami, M F, De Weger, A, Van Der Stuijt, W, Smeding, L, Bijsterveld, N R, Richter, S, Boersma, L V A, Betts, T R, Wilde, A A M, Knops, R E

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction The subcutaneous ICD (S-ICD) is developed to overcome lead-related complications and systemic infections, inherent to transvenous ICD…”
    Get full text
    Journal Article
  9. 9

    Defibrillation success after subcutaneous implantable cardioverter-defibrillator generator replacement is not affected by impedance increase by Van Der Stuijt, W, Pepplinkhuizen, S, Quast, ABE, Smeding, L, Olde Nordkamp, LRA, Wilde, AAM, Knops, RE

    Published in Europace (London, England) (24-05-2021)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Routine defibrillation testing during implant and replacement of the subcutaneous…”
    Get full text
    Journal Article
  10. 10

    Local anesthesia during S-ICD implantation gives similar post procedural pain perception as sedation by De Veld, J, Smeding, L, El-Chami, M F, Marquie, C, Nordbeck, P, Tilz, R R, Lambiase, P D, Quast, A B E, Brouwer, T F, Cassidy, C, Boersma, L V A, Betts, T R, Burke, M C, Wilde, A A M, Knops, R E

    Published in European heart journal (09-11-2023)
    “…Abstract Introduction The PRAETORIAN-DFT trial hypothesises that subcutaneous implantable cardioverter defibrillator (S-ICD) implant without defibrillation…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Exercise-optimized programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation S-ICDs by Pepplinkhuizen, S, Van Der Stuijt, W, Kooiman, KM, Quast, A-F BE, Oosterwerff, FJ, Smeding, L, Olde Nordkamp, LRA, Delnoy, P-P HM, Wilde, AAM, Knops, RE

    Published in Europace (London, England) (24-05-2021)
    “…Abstract Funding Acknowledgements Type of funding sources: None. Background Implantable cardioverter-defibrillator (ICD) therapy is associated with the risk of…”
    Get full text
    Journal Article
  14. 14

    Clinical relevance of the single-lead ECG of the Apple Watch by Pepplinkhuizen, S, Hoeksema, W F, Van Der Stuijt, W, Smeding, L, Wilde, A A M, Knops, R E

    Published in European heart journal. Digital health (22-12-2022)
    “…Abstract Introduction The Apple Watch (AW) is one of the first commercially available wearable with built-in electrocardiogram (ECG) electrodes to perform a…”
    Get full text
    Journal Article
  15. 15

    Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence by Pepplinkhuizen, S, Delnoy, PPHM, Olde Nordkamp, LRA, Kuschyk, J, Bonnemeier, H, Bijsterveld, NR, Boersma, LVA, El-Chami, MF, Smeding, L, Van Der Stuijt, W, De Weger, A, Richter, S, Betts, TR, Wilde, AAM, Knops, RE

    Published in Europace (London, England) (19-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Corporation Background The PRAETORIAN…”
    Get full text
    Journal Article
  16. 16

    Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts by Bouwman, R. Arthur, Vreden, M. Jumoke A., Hamdani, Nazha, Wassenaar, Lisan E.J., Smeding, Lonneke, Loer, Stephan A., Stienen, Ger J.M., Lamberts, Regis R.

    Published in European journal of pharmacology (25-11-2010)
    “…Volatile anesthetics protect the heart against ischemia–reperfusion injury. As an adjunct to general anesthesia, local and regional application of bupivacaine…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Clinical implications of heart-lung interactions by Smeding, L, Lust, E, Plötz, F B, Groeneveld, A B J

    Published in Netherlands journal of medicine (01-02-2010)
    “…As opposed to spontaneous respiration wherein small cyclic changes in transpulmonary, negative pressure coincide with lung volume changes, positive pressure…”
    Get full text
    Journal Article